chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At about 3:30 AM I woke up hot and sweating. I developed a hacking cough during the day and to sleep I had to take over the counter medication to sleep. I had lots of chest congestion and was producing lots of mucus. I tested on 11/7 and tested positive then went to my doctors office and tested a positive again. I was given LAGEVRIO, I am currently on the 3rd day of taking the medication I am still coughing but not as bad.
And today I had a stool, that was kind of had blood in it not much.; just a little diarrhea with a little blood in it; This is a spontaneous report from a contactable consumer.  A patient of unspecified age and gender received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number unknown) via an unspecified route of administration on 07May2021 as a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient mentioned that she just finished her 2nd shot of the COVID Vaccine on Friday and today she had a stool, that was kind of had blood in it not much. The patient experienced a stool, that was kind of had blood in it not much on 10May2021 with outcome of unknown and just a little diarrhea with a little blood in it on 10May2021 with outcome of unknown.  The patient was wondering is that some form of side effect. Therapeutic measures, if any, were not reported.   Information on lot/batch number has been requested.
COVID-19; COVID-19; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 28-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Oct2021 as dose number unknown, single (Lot number: EN6206) at the age of 27 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Depression" (unspecified if ongoing). The patient had no known allergies. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included nirmatrelvir/ ritonavir (PAXLOVID) from 13Sep2022 to 15Sep2022.
A few minutes after administering the vaccine, patient began sweating and became very dizzy and nauseous. She was monitored and given a drink of water (Epi-pen brought but deemed not necessary). She began improving after given water. 911 was called and patient evaluated by EMTs; BP and blood sugar within normal limits. Patient improved enough to go home without going to hospital.
Information has been received from a medical assistant referring to a 4 year old patient of unknown gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 25-AUG-2017, the patient was vaccinated with an improperly stored PROQUAD (dose, route, lot # and expiration date were not reported) for prophylaxis. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA004852: US-009507513-1710USA014164.
Case number PHHY2011US63522 is an initial spontaneous report received from a health care professional (pharmacist) on 14 Jul 2011. This report refers to a 29 year old female patient. She was vaccinated with MENVEO (batch number: A00151, expiry date: Jan 2013) 0.5 ml, subcutaneously on 14 Jul 2011. No adverse reaction was reported following this incorrect route of administration.
Headache, vomiting, diarrhea, fever, chills, extreme tiredness, sore arm.
Per mom pt developed a fever and redness at site right thigh, varicella was given, fever subsided and redness went away. No other problems.
red rash started around bottom area .3 months later rash begin to spread to trunk . Stomach has hives
Neck was severely itchy early morning after vaccine. Looked in the mirror 2 hours after and my neck was all red, only 2 hives but had a long red Mark (looked like a strangulation mark). Woke up today, day 2 after vaccine and looked somewhat better but as the day went on, got itchy and noticed several blotches only on neck area
pt recv vax; started high pitched crying/screaming w/in 2 hr p/ vax; unable to console or calm pt in any way; lasted 4 1/2 hr; was given apap & tepid baths;
T99 to 101;soreness in area shot given (2wk lasting);swollen glands under jaw line;nausea, h/a, diarrhea;titer negative to MMR prior to vaccine;
Hives starting 11 April; resolved temporarily with a single dose of benadryl; then recurred the following day.
arm where shot was given had a read area going down arm; slight headache / come and go headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm where shot was given had a read area going down arm) and HEADACHE (slight headache / come and go headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm where shot was given had a read area going down arm) and HEADACHE (slight headache / come and go headache). At the time of the report, VACCINATION SITE ERYTHEMA (arm where shot was given had a read area going down arm) was resolving and HEADACHE (slight headache / come and go headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided    Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: No new information was provided.
Chest heaviness, shortness of breath, rash, itchy skin to arms, and torso. 12/14/09 Medical clinic records received for DOS 11/21/09. Pt. presented with fatigue; history of SOB, resolving; and diffuse rash to arms and torso. Tx. with steroid. DX: allergic reaction-vaccination
late for dose two of Shingrix and administered a second dose; shingles which had worsened; shingles which had worsened; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of herpes zoster (for 1st dose refer case US2020AMR124024). Concurrent medical conditions included shingles.   On 1st July 2020, the patient received the 2nd dose of Shingrix. On 1st July 2020, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. In July 2020, the patient experienced shingles and condition aggravated. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the shingles, condition aggravated and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the shingles and condition aggravated to be related to Shingrix.  Additional details were reported as follows: On 1st July 2020, the patient came to the pharmacy and the patient told the pharmacist he had a bug bite or shingles. The pharmacist realized the patient was late for dose two of Shingrix and administered a second dose. Later, a physician diagnosed the patient´s condition as shingles which had worsened after the administration of the vaccine. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthtening of vaccination schedule.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR124024:same reporter
This is a spontaneous report from a contactable nurse reporting for her son via a company representative. A male patient of an unspecified age and ethnicity received the first dose of TRUMENBA via an unspecified route of administration, in the arm, on an unspecified date, at 0.5 ml single. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date after vaccination the patient arm got swollen and he was diagnosed with cellulitis. The patient received an antibiotic. The outcome was unknown at the time of report. The physician recommended to go to an ID (Infectious Disease Doctor), and he evaluated to see if the patient could get the second shot. The reporting nurse believed that cellulitis was because of the vaccination.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a female patient who received SHINGRIX for prophylaxis. On 4th March 2019, the patient received SHINGRIX. In March 2019, less than a week after receiving SHINGRIX, the patient experienced fever, chills, general body pain and weakness. On an unknown date, the outcome of the fever, chills, general body pain and weakness were unknown. It was unknown if the reporter considered the fever, chills, general body pain and weakness to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced fever, chills and body aches after receiving a dose of SHINGRIX. The patient was also feeling little bit weak. The patient was concerned if she was contagious or not.
pain in my arm that was bearable; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 24-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0182), via an unspecified route of administration, administered in Arm Left on 07Jun2021 10:30 (age at the time of vaccination 24-years-old), as a single dose for COVID-19 immunization. The patient medical history included asthma. The patient's concomitant medications were not reported. On 07Jun2021 12:30, the patient experienced pain in my arm that was bearable. Patient took Analgesic as therapeutic measures as a result of pain in my arm that was bearable. The outcome of the event was recovered on an unspecified date 2021.  Additional information is expected.
Pt had flu shot 10/2/10 and got the flu - taken to hospital 11/3/10 and cultured Type A flu. Husband called in to report that Health Dept will reculture sent vaccine info by e-mail to family.
Sore arm that she could had trouble lifting for about 24 hours; Diarrhea; Headache; This is a spontaneous report from a contactable consumer or other non healthcare professional. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 07Feb2021 (Batch/Lot Number: EN5318) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included migraine from an unknown date and unknown if ongoing She takes Aimovig monthly to prevent migraines and she was due for her monthly injection the previous day. Concomitant medication(s) included erenumab aooe (AIMOVIG) taken for migraine, start and stop date were not reported.  The patient experienced sore arm that she could had trouble lifting for about 24 hours on Feb2021 with outcome of recovered , diarrhoea and headache on Feb2021 with outcome of unknown.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a licensed vocational nurse (LVN) refers to a 6 month old female patient. Patient's medical history included vaccination on 21-APR-2014 with the first dose of ROTATEQ (2 ml, orally, lot # J002785), first dose of DTAPHBIP (default manufacturer GlaxoSmithKline reported as "GSK") (0.5 ml, left right thigh, lot # UH969AA) and with first dose of PCV 13 (default manufacturer: Pfizer reported as "PFI") (0.5 ml, right thigh, lot # G77643), and on 02-JUL-2014 with second dose of ROTATEQ (2 ml, orally, lot # J004875), second dose of DTAPHBIP (GSK) (0.5 ml, left thigh, lot # 2EB97), second dose of HIB (AVP) (0.5 ml, right thigh, lot # UH969AA) and second dose of PCV 13 (0.5 ml, right thigh, lot # H17300). Patient had no history of chickenpox. On 03-SEP-2014, the patient was vaccinated with incorrectly stored dose of ROTATEQ (third dose, lot # J004875, 2 ml, orally). Concomitant therapies included third dose of DTAPHBIP, HIB and PCV 13. No adverse symptoms were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Full body hives appeared. Friday 1/18/13 after receiving flu shot on 1/16/13. Dr appt 1/19 = steroid shot given. Hives disappeared somewhat then came back soon after. Hives still present. 1/21/13 = Dr appt w/ steroid shot & adrenaline shot given. 1/22 = Full body hives still, come & go in diff. spots. No temp.
This spontaneous report has been received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX23 lot # M041394, expiration date 23-MAY-2018 (dose and route of administration were not reported). Sterile diluent (manufacturer unknown) was used to reconstitute the vaccines. There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 34.3 degrees Fahrenheit for 30 minutes. There were previous temperature excursion of 32 to 35 degrees Fahrenheit for 4 hours and 20 minutes. Digital data logger was involved. No product quality complaint was involved. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA004383:
He has a bad /slow heart, he had a heart attach after 1st dose. He doesn't feel it's related to the vaccine. It was the heart attack was why he missed his 4 week window. He called the Dept. of Health and they said he needed to start the series over. I explained the series is now complete.
During vaccine administration did not feel needle. At night, arm was really hurting and then pain in stomach started. The pain in the stomach was not in one area but covered a large area of abdomen. The discomfort was such that couldn't fall sleep. Pain at site of injection continued and lasted about 3 more days.
The patient had swelling of the face and hives on her arms and chest. Also itching of the head, eyebrows, and ears. This started 2 days after the vaccine. She had fever and chills the night after  the vaccine
I have had a low grade fever (99.5)  for a week now.  I have had insomnia since the night of the injection.  EVERY night I wake up hot 3 hours after I went to sleep.  I have never gotten the chills, only hot.   I usually need to take a sleep aid to get back to sleep which is NOT normal for me.   Many times I wake up again 3 hours later even after the sleep aid hot.   My lack of sleep has really been hard on my daytime working and living at this point.  When I wake at night hot my temperature is usually 99.5, but has been a bit lower at times too.   I also feel that I have rapid heart rate at this time (when I try to fall back asleep)  and it seems as if my heart is beating harder than normal.  I also feel a buzzing in my head like I drank too much coffee type of feeling.  The first couple of days I felt tired and weak and a bit achy throughout the day.  The next few days after that I felt dizzy and light headed with a headache.  The first few days I also noticed slight muscle spasms throughout my arms and torso particularly when I laid down at night to go to bed and was still and relaxed.  I have been taking over the counter pain/fever pills usually for the headache.  I contacted my doctor and he said to give it a week.  It has been a week yesterday, but Dr is closed for weekends and Fridays.  I went to urgent care on Friday and they were not helpful (virtually).  They said give it 5 more days!!!!!   I am extremely tired of this and worried at how long it has been.  NOBODY I know with the first shot has had this reaction.  My wife is nervous as well and we would really like to hear something that may ease our minds at this point.  Some explanation as to why my body may be reacting this way, or if any others have had this same situation.
pt states that she had chest and back pain.  She had nausea, fever, and pain her her jaw and pain in her upper stomach.  She thought she was having a heart attack so she went to ER, .  She was given an EKG and given nitroglycerin.  She had a GI cocktail.  She had a CT scan w/ and w/out contract of her chest and her abdomen.  The did Chest X-ray,  another EKG, checked Troponin levels and blood test.  All test were negative of having a heart attack.  Pt was released to go home and relax but call 911 if she had any more chest pains and to FU w Cardiologist if needed. Pt has since recovered from all of these symptoms.
Body ache and pain especially in arthritic areas ( hands, knees, feet, neck, and back).
theres only a red circle; the guy put it in the wrong spot... The vaccine was administered in between her shoulder and elbow. Not at shoulder.; the guy put it in the wrong spot... The vaccine was administered in between her shoulder and elbow. Not at shoulder.; This is a spontaneous report from a Pfizer-sponsored program support a contactable consumer (patient's sister). A female patient (reporter's sister) of an unspecified age received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number was not reported), via an unspecified route of administration administered in between her shoulder and elbow on an unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunisation. Caller sister just got second dose. she said the guy put it in the wrong spot. She didn't have any side effects. There's only a red circle. The vaccine was administered in between her shoulder and elbow. Not at shoulder. Believes it was administered wrong. Caller had really bad reception. She said she will try calling back and hung up. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Information has been received from a medical assistant concerning a 14 year old female who on 08-APR-2008 was vaccinated with GARDASIL (lot#659437/1266U) 0.5mL IM. Concomitant therapy included MENACTRA and "TB" vaccine (manufacturer unknown). On 08-APR-28 the patient fainted after receiving GARDASIL. The medical assistant reported that the patient was rushed to the hospital via ambulance due to severe hypotension after receiving the vaccine. At the time of reporting it was unknown if the patient had recovered. The reporter felt that syncope and severe hypotension were considered to be disabling, life threatening and an other medical event. Additional information has been requested.
Fever starting 6 hrs after shot to 102. 48 hrs later injection had a short febrile seizure (20-30 sec) and was seen in ER.
11 days after receiving booster, I developed intense itching various places on body (neck, hands, chest, back, arms, legs, waist).  Any place I scratched (even lightly) would turn red, swell, and develop hives.  The reaction moves all over my body.  I saw an allergist 12/9/2021 who diagnosed the condition as Acute Dermatographic Urticaria.
Seven days after the shot, I developed intense pain and swelling at the injection site, plus some sign of itchy rash. Upper arm is swollen, tight and warm to touch. Pain shoots down through arm to pinky finger. Sensation of tingling and intense pain when moving arm.
Large swelling from elbow to breast; Welts; This case was reported by a nurse via sales rep and described the occurrence of swelling in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 29th July 2020).   On 30th November 2020, the patient received the 2nd dose of Shingrix. In December 2020, 24 hrs after receiving Shingrix, the patient experienced swelling and welts. On an unknown date, the outcome of the swelling and welts were unknown.   The reporter considered the swelling and welts to be related to Shingrix.     Additional Information: GSK Receipt Date: 27-SEP-2022 Reporter's Comments: The patient received second dose of Shingrix and 24 hours after vaccination patient experienced large swelling occurred from elbow all the way across breast and welts too. The reporter believed it was related to Shingrix. The reporter agrees to follow up from GlaxoSmithKline.
Rash on rt. lower leg. Shin bone area rash is flat-dark red-uneven 4" x 2". No pain or/itching or/heat as I report this.
Complaining of hives and itching both arms upon waking.  Noted itching of throat 1-2 hours post vaccination.  Took Benadryl with some relief.  Hive not noted anywhere but arms. Recommended she go to Urgent Care or her PCP.
Patient became distress. She became feverish, got gas and quit eating. She was taken to the ER on 10/28/08 and was evaluated. She then had another  follow-up appointment with the physician on 10/29/08. She was prescribed MYLICON drops and children's TYLENOL.
Patient has Crohn's Disease. 2-3 weeks after each inj. she developed ulcerative esophogitis. 3 endoscopies proved it not to be viral etc. but could not prove Crohns. Before the last bout was over she developed pelvic pain - was ill thru 11/05.
This spontaneous report as received from a 72 year old female consumer refers to herself with arthritis, abalone (shell fish) and Penicillin, Citanest allergies. On 06-SEP-2011 the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date and route not reported), 1 time vaccine to prevent shingles. Concomitant therapies included aspirin) manufacturer unknown, reported as aspirin), Diltiazem Hydrochloride (manufacturer unknown, reported as diltiazem), Torsemide, TOPROL, Spironolactone, Coumadin (reported as CUOMADIN and Enalapril Maleate (manufacturer unknown, reported as enalapril). On 21-SEP-2013, the patient got shingles after getting the ZOSTAVAX, the outbreak was on her breast bone, in a band to her mid-back. She sought unspecified medical attention. Pain pill (no name given) and prednisone (manufacturer unknown, reported as prednizone) for 10 days were given for adverse event. None lab diagnostics studies were performed. The adverse event was improved on therapy and the outcome of shingles was recovering. Additional information has been requested.
One hour later, client came to nurses' office with hive on face. Client was given BENADRYL 25 mg and observed. Rash worsens at injection site, and shoulders. Was much improved in 25 minutes. Client's mom picked him up and took him to see his medical provider. No further rashes were reported by mom.